Homburger advised Lotus Bakeries on its partnership with Mondelēz International to expand and grow the Lotus Biscoff cookie brand. The partnership aims to expand and grow the Lotus Biscoff cookie brand in India and
Tags :Luca Dal Molin
Kandou Holding (Kandou) has completed the initial phase of its USD 100 million Series E equity financing with legal counsel provided by Homburger. This round brings Kandou’s total equity investment to USD 280 million, further solidifying
Nanogence closed its Series A financing round, securing financing from a consortium of investors. The consortium was led by CirCap, an investment platform providing strategic private capital to innovative companies in climate-tech, healthcare and education,
As part of a strategic reorganization, the American cotton manufacturer U.S. Cotton has sold the Flawil-based producer of absorbent cotton and other products, FLAWA Consumer, to members of its management. Homburger advised U.S.
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gastrointestinal conditions, and Ironwood Pharmaceuticals, a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 mio (approx. USD 112 mio). The round was co-led by the European healthcare focused
The Finnish private equity firm Juuri Partners Oy has announced its investment in DAF Group Oy, which is responsible for managing Subway’s business in Finland and Sweden through a long-term development agreement. Through the
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, has announced that it has entered into a definitive agreement to acquire AMF Medical, the privately held Swiss developer of the Sigi™ Patch Pump,
LatticeFLow, an ETH spin-off pioneering in robust artificial intelligence (AI) having built a system that can automatically find and fix AI data and model errors, announced a USD 12 m Series A funding round led by
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, has announced the pricing of a USD 125 m underwritten offering of ordinary shares. The underwritten offering consists of 16,700,000 ordinary shares at
